Melike Ülker

Dr. Melike Ülker

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
MÜMelike Ülker
Melike Ülker
VEVolkan Erdoğu
Volkan Erdoğu
MFMerve Ekinci Fidan
Merve Ekinci Fidan
CSCelal Buğra Sezen
Celal Buğra Sezen
AÇAyşegül Çiftçi
Ayşegül Çiftçi
MMMuzaffer Metin
Muzaffer Metin
Background: We tried to demonstrate the use and benefits of hybrid-video-assisted thoracic surgery (VATS) in Pancoast tumors by comparing it with open surgical approaches. Methods: Between January 2022 and January 2024, 29 patients operated for Pancoast tumor were retrospectively evaluated. Hybrid-VATS approach was used in 14 cases, while open surgery was used in 15 cases. The two groups were compared regarding demographic characteristics, preoperative and postoperative findings. Preoperative thoracic computed tomography findings were analyzed by an experienced radiologist to guide the choice of surgical approach. Results: The hybrid-VATS technique was statistically significantly superior to the thoracotomy group in terms of operative time and preoperative bleeding amount ( P : .027, .012, respectively). There were statistically significantly fewer postoperative complications in the hybrid-VATS group (66.6% versus 21.4%, P :. 04). In preoperative thorax CT evaluation, the longest distance (>77 mm) at which the tumor invaded the chest wall was found to be statistically predictive in the choice of surgical approach (odds ratio: 7.3, P :. 01). Conclusions: Hybrid-VATS can be used in Pancoast tumor surgery in experienced centers with shorter operation time, less preoperative bleeding, and low postoperative complication rates compared with open surgery without compromising oncological principles. Preoperative thoracic CT may guide the choice of surgical approach.

17 April 2025 in Toxicology Reports
Verified
Journal Article
Open access
EDEcem Demir
Ecem Demir
KYKarolin Yanar
Karolin Yanar
PAPınar Atukeren
Pınar Atukeren
SOSerbay Ozkan
Serbay Ozkan
GŞGözde Erkanlı Şentürk
Gözde Erkanlı Şentürk
FDFazilet Dincbas
Fazilet Dincbas
Radiation-induced cardiotoxicity (RIC) is a significant adverse effect of thoracic radiotherapy (RT), leading to oxidative stress, inflammation, endothelial dysfunction, myocardial fibrosis, vascular damage, and cardiac dysfunction. Melatonin (MLT), a potent antioxidant and radioprotective agent, has been suggested to mitigate these effects. This study aims to evaluate the optimal dosage of MLT for cardioprotection following RT in a rat model. Forty-five adult male Sprague-Dawley rats were divided into five groups. The control group received 1 mL saline solution and sham irradiation. The RT-only group received 12 Gy RT in a single fraction with saline. Three experimental groups received the same RT dose with MLT at 100 mg/kg, 50 mg/kg, or 5 mg/kg. Eight weeks post-irradiation, protein oxidation, lipid peroxidation, glycoxidation, non-enzymatic redox homeostasis biomarkers, and histological changes in heart tissues were examined. In MLT-treated groups, 5 mg/kg dose was found to be more effective in preventing protein oxidation and lipid peroxidation. The levels of advanced glycation end products were significantly lower in 5 mg/kg and 50 mg/kg MLT groups compared to the RT only group, whereas no difference was found at the high dose (100 mg/kg). When Cu-Zn superoxide dismutase activity, iron ion reducing antioxidant power and total thiol groups were evaluated, we found that 5 mg/kg MLT caused a significant increase in these antioxidant parameters, while 50 mg/kg and 100 mg/kg dose caused significant increase in superoxide dismutase. Evaluation heart tissues showed that the RIC was significantly lower in all MLT-treated groups. 5 mg/kg melatonin reduces oxidative markers and RIC in rats, indicating its potential as a low-dose cardioprotective agent after RT.

18 December 2024 in Namık Kemal Tıp Dergisi
Verified
Journal Article
Closed access
MÜMelike Ülker
Melike Ülker

20 September 2024 in Namık Kemal Tıp Dergisi
Verified
Journal Article
Closed access
MMMuzaffer Meti̇n
Muzaffer Meti̇n
AÇAyşegül ÇİFTÇİ
Ayşegül ÇİFTÇİ
DKDilekhan Kizir
Dilekhan Kizir
MÜMelike Ülker
Melike Ülker
VEVolkan Erdoğu
Volkan Erdoğu
Video-Assisted Thoracoscopic Carinal Resection and Reconstruction in A Case of Primary Tracheal Tumor - Namık Kemal Medical Journal

1 January 2026 in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
Verified
Journal Article
Open access
MMMeral Selin Onay Mahmuti
Meral Selin Onay Mahmuti
MÜMelike Ülker
Melike Ülker
ACAyşegul Ciftci
Ayşegul Ciftci
NINisa Yildiz Ilhan
Nisa Yildiz Ilhan
MFMerve Ekinci Fidan
Merve Ekinci Fidan
MMMuzaffer Metin
Muzaffer Metin
The impact of preoperative predisposing factors on postoperative complications in patients undergoing pneumonectomy for non-small cell lung cancer (NSCLC) remains a critical issue. Understanding these factors may provide valuable insights into postoperative risks and complications. This study aimed to evaluate the influence of preoperative predisposing factors (comorbidities) on the development of postoperative complications in patients undergoing pneumonectomy for NSCLC. Using the age-adjusted Charlson Comorbidity Index (a-CCI), we sought to identify risk factors that potentially contribute to complications and investigate their impact on survival. In this retrospective study, 236 patients who underwent pneumonectomy between February 2018 and February 2023 were analyzed. Demographic characteristics, comorbidities based on the a-CCI, surgical details, postoperative complications classified according to the Clavien–Dindo system, and survival outcomes were evaluated. Postoperative complications occurred in 44.1% of patients (n=104). The development of complications was significantly associated with right-sided pneumonectomy (p=0.018), prolonged operative time (p=0.002), and increased intraoperative blood loss (p<0.001). Although the a-CCI failed to predict postoperative complications, it demonstrated a significant association with survival outcomes. Patients with higher a-CCI scores had markedly reduced mean survival times (p=0.001). In patients undergoing pneumonectomy for NSCLC, right-sided resections, prolonged operative duration, and excessive intraoperative blood loss increase the risk of postoperative complications. While the a-CCI is limited in predicting postoperative complications, it serves as a valuable prognostic indicator of survival. Assessing these factors may guide risk stratification and optimize perioperative management strategies in surgical candidates.

1 August 2025 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
MÜMelike Ülker
Melike Ülker
VEVolkan Erdoğu
Volkan Erdoğu
MFMerve Ekinci Fidan
Merve Ekinci Fidan
AÇAyşegül Çiftçi
Ayşegül Çiftçi
EKEzgi Kılıçaslan
Ezgi Kılıçaslan
MMMuzaffer Metin
Muzaffer Metin
Introduction: The safety and efficacy of video-assisted thoracoscopic surgery (VATS) in pneumonectomy for patients with non-small cell lung cancer (NSCLC) were compared with open surgery. Methods: Between January 2020 and October 2024, we conducted a retrospective review of 177 pneumonectomy cases at our center. Fifty-eight cases were performed using VATS (VATS Group), while 119 were performed using thoracotomy (Thoracotomy Group). Results: The average age of the patients was 61.2 ± 8.3 years (range: 39–83), and the majority were male ( n = 155, 87.6%). Perioperative blood loss (VATS Group: 152 ± 131 mL, range 100–700 mL versus Thoracotomy Group: 314 ± 455 mL, range 100–3500 mL) and hospital stay durations (VATS Group: 5.3 ± 2.4 days, range 3–13 versus Thoracotomy Group: 7.5 ± 4.1 days, range 2–22) were found to be significantly lower in the VATS Group ( P < .001 for both). Left-sided resections were more frequent in the VATS Group (74% versus 57.1%, P = .049), and tumor sizes were observed to be smaller (4.8 ± 2.2 cm versus 6.2 ± 3.6 cm, P = .009). No significant differences were observed between the groups in terms of postoperative early morbidity and 30-day mortality ( P = .784 and P = .549, respectively). Conclusion: VATS pneumonectomy is a method that can be preferred by experienced centers in patients with NSCLC, offering the advantages of reduced perioperative bleeding and shorter hospital stays compared with the thoracotomy approach, without compromising oncological principles.